Cui Jisong - Net Worth and Insider Trading

Cui Jisong Net Worth

The estimated net worth of Cui Jisong is at least $478 Million dollars as of 2024-06-21. Cui Jisong is the 2101 Beneficial owner of InnoCare Pharma Ltd and owns about 100,538,916 shares of InnoCare Pharma Ltd (HKSE:09969) stock worth over $478 Million. Details can be seen in Cui Jisong's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Cui Jisong has not made any transactions after 2024-05-30 and currently still holds the listed stock(s).

Transaction Summary of Cui Jisong

To

Cui Jisong Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Cui Jisong owns 1 companies in total, including InnoCare Pharma Ltd (HKSE:09969) .

Click here to see the complete history of Cui Jisong’s form 4 insider trades.

Insider Ownership Summary of Cui Jisong

Ticker Comapny Transaction Date Type of Owner
HKSE:09969 InnoCare Pharma Ltd 2024-05-31

Cui Jisong Latest Holdings Summary

Cui Jisong currently owns a total of 1 stock. Cui Jisong owns 100,538,916 shares of InnoCare Pharma Ltd (HKSE:09969) as of May 30, 2024, with a value of $478 Million.

Latest Holdings of Cui Jisong

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:09969 InnoCare Pharma Ltd 2024-05-30 100,538,916 4.75 477,559,851

Holding Weightings of Cui Jisong


Cui Jisong Form 4 Trading Tracker

According to the SEC Form 4 filings, Cui Jisong has made a total of 9 transactions in InnoCare Pharma Ltd (HKSE:09969) over the past 5 years, including 2 buys and 3 sells. The most-recent trade in InnoCare Pharma Ltd is the acquisition of 316,000 shares on May 30, 2024, which cost Cui Jisong around $0.

Insider Trading History of Cui Jisong

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Cui Jisong Trading Performance

GuruFocus tracks the stock performance after each of Cui Jisong's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Cui Jisong is -16.31%. GuruFocus also compares Cui Jisong's trading performance to market benchmark return within the same time period. The performance of stocks bought by Cui Jisong within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Cui Jisong's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Cui Jisong

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 1.68 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -0.04 LIMIT LIMIT LIMIT LIMIT LIMIT

Cui Jisong Ownership Network

Ownership Network List of Cui Jisong

No Data

Ownership Network Relation of Cui Jisong

Insider Network Chart

Cui Jisong Owned Company Details

What does InnoCare Pharma Ltd do?

Who are the key executives at InnoCare Pharma Ltd?

Cui Jisong is the of InnoCare Pharma Ltd. Other key executives at InnoCare Pharma Ltd include 2201 Interest of corporation controlled by you The Goldman Sachs Group, Inc. , 2101 Beneficial owner King Bridge Investments Limited , and 2201 Interest of corporation controlled by you Pang Kee Chan Hebert .

InnoCare Pharma Ltd (HKSE:09969) Insider Trades Summary

Over the past 18 months, Cui Jisong made 6 insider transaction in InnoCare Pharma Ltd (HKSE:09969) with a net sale of 5,684,000. Other recent insider transactions involving InnoCare Pharma Ltd (HKSE:09969) include a net sale of 259,000 shares made by The Goldman Sachs Group, Inc. , a net sale of 6,000,000 shares made by Zhao Renbin , and a net sale of 0 shares made by Shi Yigong .

In summary, during the past 3 months, insiders sold 625,000 shares of InnoCare Pharma Ltd (HKSE:09969) in total and bought 316,000 shares, with a net sale of 309,000 shares. During the past 18 months, 18,625,000 shares of InnoCare Pharma Ltd (HKSE:09969) were sold and 316,000 shares were bought by its insiders, resulting in a net sale of 18,309,000 shares.

InnoCare Pharma Ltd (HKSE:09969)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

InnoCare Pharma Ltd Insider Transactions

No Available Data

Cui Jisong Mailing Address

Above is the net worth, insider trading, and ownership report for Cui Jisong. Currently GuruFocus does not have mailing address information for Cui Jisong.

Discussions on Cui Jisong

No discussions yet.